| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 790 | $80 | $61.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $130 | $29.3K |
| J0897 | Injection, denosumab, 1 mg | 1,440 | $20 | $25.9K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 200 | $130 | $25.4K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 100 | $160 | $16.2K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 150 | $70 | $10.8K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 30 | $270 | $8.7K |
| G0008 | Administration of influenza virus vaccine | 160 | $30 | $4.6K |
| 90732 | The provider intramuscularly or subcutaneously injects pneumococcal polysaccharide vaccine in an individual two years or older. This vaccine provides protection against meningitis and pneumonia that… | 30 | $130 | $4.2K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 30 | $140 | $3.7K |